Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent

International Journal of Gynecological Cancer

Volumn 18, Issue 3, 2008, Pages 525-533

  Narayan, K ^a,b   Fisher, R J ^a   Bernshaw, D ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b NONE   (Australia)

Author keywords

Cervical neoplasm; Corpus invasion; FIGO; Patterns of failure; Prognostic factors

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGE; AGED; ANESTHESIA; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 43449103341     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01050.x     Document Type: Article

References (17)

1. Thomas GM. Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy. N Engl J Med 1999 340 : 1198 200.
2. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer [see comments]. N Engl J Med 1999 340 : 1137 43.
3. Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer 2006 16 : 623 30.
4. Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer 2003 13 : 657 63.
5. Kalbfleisch JD, Prentice RL. The statistical analysis of failure data. New York, NY : John Wiley & Sons Inc, 1980.
6. Meanwell CA, Kelly KA, Wilson S et al. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases. Br Med J (Clin Res Ed) 1988 296 : 386 91.
7. Kapp KS, Stuecklschweiger GF, Kapp DS et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998 42 : 531 40.
8. Ferrigno R, dos Santos Novaes PE, Pellizzon AC et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001 50 : 1123 35.
9. Lanciano R, Calkins A, Bundy BN et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2005 23 : 8289 95.
10. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 2004 22 : 872 80.
11. Petereit DG, Sarkaria JN, Potter DM, Schink JC. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence - the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 1999 45 : 1267 74.
12. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998 41 : 307 17.
13. Ohara K, Tsunoda H, Nishida M et al. Use of small pelvic field instead of whole pelvic field in postoperative radiotherapy for node-negative, high-risk stages I and II cervical squamous cell carcinoma. Int J Gynecol Cancer 2003 13 : 170 6.
14. Suit HD, Westgate SJ. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 1986 12 : 453 8.
15. Durrance FY, Fletcher GH, Rutledge FN. Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus. Am J Roentgenol Radium Ther Nucl Med 1969 106 : 831 8.
16. Perez CA, Grigsby PW, Nene SM et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992 69 : 2796 806.
17. Keys HM, Bundy BN, Stehman FB et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003 89 : 343 53.